What is Utah Medical Products's net change in cash?

Utah Medical Products (UTMD) reported net change in cash of $1.65M in Q1 2026.

How has Utah Medical Products's net change in cash changed year-over-year?

Utah Medical Products's net change in cash increased by 372.8% year-over-year, from $349K to $1.65M.

What is the long-term trend for Utah Medical Products's net change in cash?

Over 3 years (2022 to 2025), Utah Medical Products's net change in cash has grown at a -41.8% compound annual growth rate (CAGR), from $14.08M to $2.78M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Utah Medical Products UTMD Net Change in Cash

Net Change in Cash at other companies

Becton, Dickinson and CompanyBDX

$64M+194%

TFX

TeleflexTFX

-$84.85M-734%

The Cooper Companies, Inc.COO

$14M-7.9%

IAR

Integra LifeSciencesIART

$1.76M+124%

Merit Medical SystemsMMSI

$41.7M+121%

PDE

Pro-Dex, Inc.PDEX

$2.04M-53.7%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's net change in cash?: Utah Medical Products (UTMD) reported net change in cash of $1.65M in Q1 2026.
How has Utah Medical Products's net change in cash changed year-over-year?: Utah Medical Products's net change in cash increased by 372.8% year-over-year, from $349K to $1.65M.
What is the long-term trend for Utah Medical Products's net change in cash?: Over 3 years (2022 to 2025), Utah Medical Products's net change in cash has grown at a -41.8% compound annual growth rate (CAGR), from $14.08M to $2.78M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.